Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

2,235 evidence items · page 72 / 90

91.8 %In scenario 3, time spent at a facility awaiting sample batching and transport accounted for 91.8% of total turnaround time for HIV viral load monitoring.

KenyaVIH/sidapublished 2024Health policy and planningPubMeddocument of 15 observations

86 %Overall, 86% of vaccine recipients in the DNA prime - rAd5 boost group responded to the HIV-1 proteins by an interferon-gamma (IFN-γ) ELISPOT.

KenyaVIH/sidapublished 2010PloS oneeurope_pmcdocument of 4 observations

83 %Among ART-naïve persons, viral suppression at year 3 was 83% in the intervention arm and 79% in the control arm.

KenyaVIH/sidapublished 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 4 observations

26 %Youth living with HIV who had self-disclosed experienced stigma at a prevalence of 26%, compared to 3% among those who had not self-disclosed.

KenyaVIH/sidapublished 2021AIDS and behaviorPubMeddocument of 13 observations

40.9 %More women living with HIV who were lost to follow-up (40.9%) than those retained in care (7.7%) were not virally suppressed at study enrollment.

KenyaVIH/sidapublished 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 13 observations

1,408 partnersFrom March to December 2021, 1408 partners reporting a prior HIV diagnosis were excluded from analyses.

KenyaVIH/sidaobserved March to December 2021published 2024Journal of the International AIDS SocietyPubMeddocument of 15 observations

14.3 %Eight women (14.3%) had a detectable HIV viral load with a mean of 12,439 copies/mL.

KenyaVIH/sidapublished 2025International journal of STD & AIDSPubMeddocument of 8 observations

40.7 per_1000The age- and sex-adjusted mortality rate in the HIV-infected population was 40.7 per 1,000 population.

KenyaVIH/sidapublished 2021PloS onePubMeddocument of 14 observations

92 %At 12 months follow-up, 92% of female partners of male partners (FPPs) were taking antiretroviral treatment (ART).

KenyaVIH/sidaobserved 12 months follow-uppublished 2024Journal of the International AIDS SocietyPubMeddocument of 10 observations

3 %Only three (3%) of 106 enrolled PrEP clients refilled PrEP at a participating private pharmacy.

KenyaVIH/sidaobserved November 2020 to November 2021published 2024BMC health services researchPubMeddocument of 5 observations

1,000 copies/mlMost of the participants had viral loads of more than 1000 copies/ml during all the three visits.

KenyaVIH/sidapublished 2021The Pan African medical journalPubMeddocument of 3 observations

4.6 %Among HIV-1 seronegative women prostitutes in Nairobi (Kenya), 4.6% had oral mucosal lesions.

Kenyaoral mucosal lesions · VIH/sidapublished 1989Journal of Oral Pathology and MedicineOpenAlexdocument of 8 observations

67.7 %For the 31 patients with an undetectable viral load, PR and RT sequences were obtained for 67.7% and 61.3% of the whole-blood-cell DNA preparations and for 54.8% and 58.1% of the DBS DNA preparations, respectively.

KenyaVIH/sidapublished 2007Journal of clinical microbiologyeurope_pmcdocument of 4 observations

56.3 %56.3% of caregivers linked childhood tuberculosis to HIV in Gem Sub County, Siaya County, Kenya.

Kenyatuberculose · VIH/sidapublished 2026PloS onePubMeddocument of 9 observations

3 %At baseline, 3% of participants were HIV-positive.

KenyaVIH/sidapublished 2022BMC public healthPubMeddocument of 8 observations

71.4 %Among viral failures on zidovudine (AZT)-based regimens, 71.4% had AZT-related drug resistance.

KenyaVIH/sidapublished 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 14 observations

2.65 %HIV prevalence was 2.65% among patients with risk-score 16–29.

KenyaVIH/sidaobserved September 2017 to May 2018published 2021AIDS and behaviorPubMeddocument of 4 observations

0.99 relative_riskAt visits where women reported sexual activity in the past week, the relative risk of 100% condom use at postmenopausal versus premenopausal visits was 0.99 (95% confidence interval: 0.87 to 1.13).

KenyaVIH/sidapublished 2017Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 5 observations

70.4 %70.4% of men who have sex with men who met partners via both virtual and physical sites (DMSM) in Kenya reported an HIV test in the previous six months.

KenyaVIH/sidaobserved 2019published 2020Journal of the International AIDS SocietyPubMeddocument of 12 observations

88.2 %Site-specific viral rebound rates were 88.2% in Nakuru, 18.6% in Malindi, and 18.0% in Meru.

KenyaVIH/sidapublished 2020International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument of 9 observations

2.4 %The co-occurrence of PSA detection and detectable VL at the same visit was observed in 2.4% of visits.

KenyaPSA detection · VIH/sidapublished 2021AIDS and behavioreurope_pmcdocument of 2 observations

27 %Unprotected intercourse was reported at 546 out of 2037 (27%) pre-seroconversion visits.

KenyaVIH/sidapublished 2006AIDS (London, England)europe_pmcdocument of 3 observationsDOI 10.1097/01.aids.0000247119.12327.e6

26.7 %HIV prevalence was 26.7% among men who have sex with men who solely met partners via virtual sites (VMSM) in Kenya.

KenyaVIH/sidaobserved 2019published 2020Journal of the International AIDS SocietyPubMeddocument of 12 observations

88 %At 12 months follow-up, 1512 (88%) female index clients with HIV were taking antiretroviral treatment.

KenyaVIH/sidaobserved 12 months follow-uppublished 2023The Lancet. Global healthPubMeddocument of 11 observations

-0.3 unitsThe microclinic intervention reduced HIV-associated stigma by -0.3 units on a 5-point scale over one year of follow-up.

KenyaVIH/sidaobserved one year of follow-uppublished 2021PloS onePubMeddocument of 9 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.